Funding for this research was provided by:
Association France Alzheimer (InductAlz)
Agence Nationale de la Recherche (NeurATRIS - ANR-11-INBS-0011)
Ministère de l'Enseignement Supérieur, de la Recherche, et de l'Innovation (PhD Thesis)
Fondation pour la Recherche Médicale (PhD Thesis)
Received: 18 May 2022
Accepted: 16 July 2022
First Online: 16 August 2022
: All experimental procedures were conducted in accordance with the European Community Council Directive 2010/63/UE and approved by local ethics committees (CEtEA-CEA DSV IdF N°44, France) and the French Ministry of Education and Research (A17_083 authorization), and in compliance with the 3R guidelines. Animal care was supervised by a dedicated veterinarian and animal technicians. Human endpoints concerning untreatable continuous suffering signs and prostrations were used and not reached during the study.
: Does not apply to the content of this article.
: The authors declare that they have no competing interests.